POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	1bp1	BACTERICIDAL/PERMEAB ILITY-INCREASING PROTEIN (Homo sapiens)	4 / 5	PHE A 425 PHE A 262 LEU A 333 PRO A 442	PC1  A 778 (-4.7A) None None None	1.41A	21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	1e33	ARYLSULFATASE A (Homo sapiens)	4 / 5	HIS P 226 PHE P 144 LEU P 197 PRO P 192	None	1.36A	21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	1vzo	RIBOSOMAL PROTEIN S6 KINASE ALPHA 5 (Homo sapiens)	4 / 5	PHE A 318 PHE A 317 LEU A 294 PRO A 254	None	1.35A	22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	1ygu	LEUKOCYTE COMMON ANTIGEN (Homo sapiens)	4 / 5	HIS A 788 PHE A 711 LEU A 772 PRO A 742	None	1.25A	18.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	1zrz	PROTEIN KINASE C, IOTA (Homo sapiens)	4 / 5	PHE A 513 PHE A 512 LEU A 488 PRO A 443	None	1.33A	22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	2cso	PLECKSTRIN (Homo sapiens)	4 / 5	PHE A  44 PHE A 108 LEU A  77 PRO A 100	None	1.33A	18.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	2y7j	PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM (Homo sapiens)	4 / 5	PHE A 291 PHE A 290 LEU A 272 PRO A 232	None	1.40A	22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	2yd0	ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 (Homo sapiens)	4 / 5	PHE A 194 HIS A  96 PHE A 199 PRO A 426	None	1.21A	16.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3a62	RIBOSOMAL PROTEIN S6 KINASE BETA-1 (Homo sapiens)	4 / 5	PHE A 352 PHE A 351 LEU A 328 PRO A 292	None	1.28A	21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3na0	CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME, MITOCHONDRIAL (Homo sapiens)	4 / 5	PHE A 475 HIS A 338 LEU A 352 PRO A 437	None	1.24A	21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 5	PHE A 408 PHE A 407 LEU A 384 PRO A 348	PHE  A 408 ( 1.3A) PHE  A 407 ( 1.3A) LEU  A 384 ( 0.6A) PRO  A 348 ( 1.1A)	1.23A	21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3qyb	TBC1 DOMAIN FAMILY MEMBER 4 (Homo sapiens)	4 / 5	PHE A 975 HIS A1022 PHE A 981 LEU A 878	None	1.40A	22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3qye	TBC1 DOMAIN FAMILY MEMBER 1 (Homo sapiens)	4 / 5	PHE A 856 HIS A 903 PHE A 862 LEU A 758	None	1.42A	22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3rmv	GLYCOGENIN-1 (Homo sapiens)	4 / 5	PHE A 100 HIS A 212 PHE A 137 PRO A 126	None MN  A 263 ( 3.3A) None None	1.30A	22.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	4bn5	NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL (Homo sapiens)	4 / 5	PHE A 180 HIS A 248 LEU A 298 PRO A 326	SR7  A1396 (-3.7A) SR7  A1396 ( 3.5A) None None	0.76A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	4bn5	NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL (Homo sapiens)	4 / 5	PHE A 180 HIS A 248 PHE A 294 LEU A 298	SR7  A1396 (-3.7A) SR7  A1396 ( 3.5A) SR7  A1396 (-3.5A) None	0.60A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	4crs	SERINE/THREONINE-PRO TEIN KINASE N2 (Homo sapiens)	4 / 5	PHE A 916 PHE A 915 LEU A 892 PRO A 856	None	1.35A	21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	4gnk	1-PHOSPHATIDYLINOSIT OL 4,5-BISPHOSPHATE PHOSPHODIESTERASE BETA-3 (Homo sapiens)	4 / 5	PHE B  28 PHE B 120 LEU B  90 PRO B  81	None	1.45A	13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	4gv1	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 5	PHE A 408 PHE A 407 LEU A 384 PRO A 348	None	1.27A	21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	4mk0	BETA-ADRENERGIC RECEPTOR KINASE 1 (Homo sapiens)	4 / 5	PHE A 453 PHE A 452 LEU A 429 PRO A 390	None	1.28A	17.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	4nge	PRESEQUENCE PROTEASE, MITOCHONDRIAL (Homo sapiens)	4 / 5	PHE D  88 PHE D 148 LEU D 111 PRO D 122	None	1.35A	16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	4nge	PRESEQUENCE PROTEASE, MITOCHONDRIAL (Homo sapiens)	4 / 5	PHE D 168 HIS D 254 PHE D 169 LEU D 172	None None MLY  D 287 ( 4.5A) None	1.44A	16.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	5btr	NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-1 (Homo sapiens)	4 / 5	PHE A 297 HIS A 363 LEU A 418 PRO A 447	None	0.82A	32.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	5fyq	NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2 (Homo sapiens)	4 / 5	PHE A 119 HIS A 187 LEU A 239 PRO A 268	None	1.14A	44.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	5j3p	TYROSYL-DNA PHOSPHODIESTERASE 2 (Homo sapiens)	4 / 5	PHE A 259 PHE A 319 LEU A 334 PRO A 290	None	1.39A	24.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	5j6s	ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 (Homo sapiens)	4 / 5	PHE A 211 HIS A 111 PHE A 216 PRO A 443	None	1.37A	15.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	5m23	WD REPEAT-CONTAINING PROTEIN 5 (Homo sapiens)	4 / 5	PHE A 263 PHE A 219 LEU A 234 PRO A 216	7DC  A 401 (-3.9A) None None None	1.44A	19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	5uuu	BETA-ADRENERGIC RECEPTOR KINASE 1 (Homo sapiens)	4 / 5	PHE A 453 PHE A 452 LEU A 429 PRO A 390	None	1.25A	22.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	6byn	WD REPEAT-CONTAINING PROTEIN 5 (Homo sapiens)	4 / 5	PHE W 263 PHE W 219 LEU W 234 PRO W 216	None	1.45A	16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	1i4e	CASPASE-8 (Homo sapiens)	4 / 6	PHE B2476 PHE B2356 GLU B2445 VAL B2446	None	1.25A	19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	1wao	SERINE/THREONINE PROTEIN PHOSPHATASE 5 (Homo sapiens)	4 / 6	GLU 1 305 PHE 1 335 GLU 1 318 VAL 1 319	None	1.41A	18.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3e7g	NITRIC OXIDE SYNTHASE, INDUCIBLE (Homo sapiens)	4 / 6	PHE A 302 ARG A 301 GLU A 343 GLU A 394	None	1.02A	20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3e7g	NITRIC OXIDE SYNTHASE, INDUCIBLE (Homo sapiens)	4 / 6	PHE A 302 ARG A 301 GLU A 394 VAL A 395	None	1.39A	20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3h68	SERINE/THREONINE-PRO TEIN PHOSPHATASE 5 (Homo sapiens)	4 / 6	GLU A 305 PHE A 335 GLU A 318 VAL A 319	None	1.36A	22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3lgg	ADENOSINE DEAMINASE CECR1 (Homo sapiens)	4 / 6	PHE A  60 GLU A  68 PHE A  73 GLU A 208	None	1.03A	20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3o47	ADP-RIBOSYLATION FACTOR GTPASE-ACTIVATING PROTEIN 1, ADP-RIBOSYLATION FACTOR 1 (Homo sapiens)	4 / 6	ARG A 239 GLU A 243 PHE A 212 VAL A 153	None	1.36A	21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3thz	DNA MISMATCH REPAIR PROTEIN MSH2 (Homo sapiens)	4 / 6	ARG A  55 GLU A  56 PHE A  88 VAL A  78	None	1.41A	14.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3uem	PROTEIN DISULFIDE-ISOMERASE (Homo sapiens)	4 / 6	ARG A 452 PHE A 446 GLU A 433 VAL A 432	None	1.35A	22.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	4bn5	NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL (Homo sapiens)	4 / 6	GLU A 177 PHE A 294 GLU A 323 VAL A 324	SR7  A1396 (-4.4A) SR7  A1396 (-3.5A) None None	1.35A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	4bn5	NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL (Homo sapiens)	4 / 6	PHE A 157 GLU A 177 PHE A 294 VAL A 324	SR7  A1396 (-3.7A) SR7  A1396 (-4.4A) SR7  A1396 (-3.5A) None	1.32A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	5iy9	DNA-DIRECTED RNA POLYMERASE II SUBUNIT RPB1 (Homo sapiens)	4 / 6	PHE A 800 GLU A 738 PHE A 737 VAL A 713	None	1.30A	8.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	5kjm	N-LYSINE METHYLTRANSFERASE SMYD2 (Homo sapiens)	4 / 6	PHE A 184 PHE A  34 GLU A 235 VAL A 236	6TM  A 502 (-3.4A) None None None	1.17A	22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	5oaf	RUVB-LIKE 1 (Homo sapiens)	4 / 6	ARG A 118 GLU A 114 GLU A 100 VAL A 101	None	1.36A	13.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	5oed	GTGE RAS-RELATED PROTEIN RAB-32 (Homo sapiens; Salmonella enterica)	4 / 6	PHE B  88 ARG B  87 GLU B  86 GLU A 198	None None GDP  B 900 (-4.0A) None	1.21A	14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_A_BBIA403_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	6fae	ADP-RIBOSYLATION FACTOR 1 (Homo sapiens)	4 / 6	GLU B 113 PHE B  82 GLU B 106 VAL B  23	None	1.16A	13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H4D_H_BBIH405_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	5jjd	COLLAGEN TYPE IV ALPHA-3-BINDING PROTEIN (Homo sapiens)	4 / 4	ARG B 442 GLU B 446 PHE B 579 VAL B 525	PGE  B 604 ( 3.5A) PGE  B 604 ( 3.4A) PGE  B 604 (-2.7A) PGE  B 604 ( 4.6A)	1.34A	22.18